Navigation Links
Mass. Eye and Ear granted $30,000 medical eye research fellowship
Date:1/22/2012

Boston (Jan. 23, 2012) Research to Prevent Blindness (RPB) has awarded Massachusetts Eye and Ear, a teaching affiliate of Harvard Medical School, a $30,000 Medical Student Eye Research Fellowship. The award will support the work of Ms. Mamta Shah.

The award will allow Ms. Shah to participate in research under the mentorship of Mass. Eye and Ear Glaucoma Service Director Dr. Louis Pasquale in collaboration with Dr. Suzanne Freitag, Director of the Mass. Eye and Ear Ophthalmic Plastic Surgery Service. Their study will pursue the development of an algorithm to objectively evaluate anatomical changes in the eye believed to be associated with certain types of eye drops used to treat glaucoma.

"We are grateful to Research to Prevent Blindness for their continued support of eye research at Mass. Eye and Ear. They are one of the important contributors to our effort to find better treatments for patients with debilitating eye conditions," said Dr. Joan W. Miller, Chief of Ophthalmology at Mass. Eye and Ear and Mass General, and Chair of Ophthalmology at Harvard Medical School.


'/>"/>

Contact: Vannessa Carrington
Vannessa_Carrington@meei.harvard.edu
Massachusetts Eye and Ear Infirmary
Source:Eurekalert

Page: 1

Related medicine news :

1. Mass. General researchers find novel way to prevent drug-induced liver injury
2. Mass. General Cancer Center and Vall dHebron Institute of Oncology biomarker alliance
3. Uninsured patients in Mass. still mainly the working poor, despite states health reform
4. Mass. General team identifies new class of antiangiogenesis drugs
5. Mass. General study reveals how lung cancers evolve in response to targeted treatment
6. Mass. Health Reform Hasnt Halted Medical Bankruptcies
7. Mass. General enters collaboration to develop new approach to capturing circulating tumor cells
8. Mass. doctor invents product to curb hospital-acquired infections
9. Researchers to study effects of Mass. health reform
10. Mass. General Hospital, Iacocca Foundation announce completion of Phase I diabetes trial
11. Mass. Eye and Ear receives NEI grant renewal for growing clinical/scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... , ... June 23, 2017 , ... MD Now ... This is MD Now’s 28th facility overall and marks the urgent care center's eighth ... one mile North of The Falls shopping mall. The new clinic offers a wide ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ross Insurance Agency ... the Federal Emergency Management Agency’s (FEMA) recent update of flood zones, more people ... the Biggert-Waters Act was enacted to reflect the actual risk in flood zone ...
(Date:6/23/2017)... Francisco, CA (PRWEB) , ... June 23, 2017 , ... ... on 26th June, 2017 from 9 am to 3 pm to present to graduate ... The program is an original curriculum project led by The Health Improvement Service ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... assistance and financial planning services to communities in the greater Chicago metropolitan area, ... to offer assistance to underprivileged youth in Chicago. , Founded in 1897, Hephzibah ...
(Date:6/23/2017)... Morgantown, WV (PRWEB) , ... June 23, 2017 ... ... asset protection services and personal financial planning to families and business owners in ... Stepping Stones organization to help provide services to differently abled residents in the ...
Breaking Medicine News(10 mins):
(Date:6/19/2017)... , June 19, 2017  Researchers from DRUGSCAN ... that they will host a live, complimentary webinar titled, ... the benchtop to the real world" on Wednesday June ... This webinar will feature interviews with ... look into the manipulation techniques abusers use to prepare ...
(Date:6/14/2017)... June 14, 2017 The Bio Supply Management ... City of Fremont and the Biomedical Manufacturing ... industry in California by providing ... networking, and fostering workforce development. The primary focus of ... of start-ups, as well as small and mid-sized biomedical ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: